Co-Diagnostics, Inc. Announces Third Quarter 2025 Earnings Release Date and Webcast

Rhea-AI Summary

Co-Diagnostics (NASDAQ: CODX) will release its third quarter 2025 financial results on Thursday, November 13, 2025 after the market close.

The company will host a conference call and webcast the same day at 4:30 p.m. ET with Dwight Egan (CEO), Brian Brown (CFO), and Andrew Benson (Head of Investor Relations). The live webcast is available at ir.co-dx.com on the Events & Webcasts page, and the conference call numbers are 1-888-880-3330 (toll free) and 1-646-357-8766 (toll). A recorded replay will be posted on the company's website for those unable to attend live.

SALT LAKE CITY, Oct. 31, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced today it will release its third quarter 2025 financial results on Thursday, November 13, 2025, after the market close. The Company will also host a conference call and webcast on the same day at 4:30 p.m. ET to discuss its financial results with analysts. Management on the call will include Dwight Egan, Chief Executive Officer, Brian Brown, Chief Financial Officer, and Andrew Benson, Head of Investor Relations.

The conference call and webcast will be available via:

Webcast: ir.co-dx.com on the Events & Webcasts page, or accessible directly here

Conference Call: 1-888-880-3330 (Toll Free) or 1-646-357-8766 (Toll)

If you are unable to participate during the live webcast, the call will be recorded and later made available on the Company's website.

About Co-Diagnostics, Inc.
Co-Diagnostics, Inc. (Nasdaq: CODX), a Utah corporation, is a molecular diagnostics company that develops, manufactures and markets state-of-the-art diagnostics technologies. The Company's technologies are utilized for tests that are designed to detect and/or analyze nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR at-home and point-of-care platform (subject to regulatory review and not currently for sale) and to identify genetic markers for use in applications other than infectious disease.

View original content to download multimedia:https://www.prnewswire.com/news-releases/co-diagnostics-inc-announces-third-quarter-2025-earnings-release-date-and-webcast-302600837.html

SOURCE Co-Diagnostics

FAQ

When will Co-Diagnostics (CODX) report Q3 2025 results?

Co-Diagnostics will release Q3 2025 results on November 13, 2025 after the market close.

What time is the Co-Diagnostics (CODX) Q3 2025 earnings call and webcast?

The conference call and webcast are scheduled for 4:30 p.m. ET on November 13, 2025.

Who will speak on the Co-Diagnostics (CODX) Q3 2025 earnings call?

Management participating includes Dwight Egan (CEO), Brian Brown (CFO), and Andrew Benson (Head of Investor Relations).

How can investors access the Co-Diagnostics (CODX) webcast for Q3 2025?

The live webcast will be available on the Events & Webcasts page at ir.co-dx.com.

What are the dial-in numbers for the Co-Diagnostics (CODX) Q3 2025 conference call?

Dial in at 1-888-880-3330 (toll free) or 1-646-357-8766 (toll).

Will the Co-Diagnostics (CODX) Q3 2025 earnings call be available after the live event?

Yes, the call will be recorded and later made available on the company's investor website.